FIELD: chemistry.
SUBSTANCE: invention relates to phosphoramidate alkylator prodrugs which can be used to treat cancer separately or combined with other anti-tumour agents, having formula: 
, where each X4 denotes Cl or Br.
EFFECT: obtaining novel compounds, having antiproliferative activity and pharmaceutical compositions based on said compositions.
9 cl, 7 dwg, 56 ex, 43 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ADMINISTERING HYPOXICALLY ACTIVATED PRODRUGS AND MEANS OF PREVENTING ANGIOGENESIS, FOR TREATING CANCER | 2011 |
|
RU2597844C2 |
| COMPOUNDS AND COMPOSITIONS FOR STABILISATION OF HYPOXIA INDUCED FACTOR-2 ALPHA AS METHOD OF CANCER MEDICAL TREATMENT | 2012 |
|
RU2602498C2 |
| COMBINED THERAPY FOR CANCER TREATMENT | 2013 |
|
RU2699546C2 |
| APPLICATION OF MEDICATIONS, BINDING EDG-RECEPTOR, IN TREATMENT OF CANCER DISEASE | 2008 |
|
RU2426555C2 |
| COMBINED THERAPY BY USING PENTAFLUOROBENZENE SULFONAMIDES | 2000 |
|
RU2268054C2 |
| APPLICATION OF EDG-RECEPTOR BINDING AGENT IN CANCER THERAPY | 2003 |
|
RU2358717C2 |
| COMPOSITION OF COMPOUNDS AND WAYS OF THEIR APPLICATION | 2015 |
|
RU2659068C1 |
| COMPLEX THERAPY FOR CANCER TREATMENT | 2018 |
|
RU2810487C2 |
| METHOD FOR REDUCING MULTI-DRUG RESISTANCE WITH USING INOSITOL TRIPYROPHOSPHATE | 2010 |
|
RU2563127C2 |
| COMBINATIONS FOR TREATING DISEASES CONTAINING CELL PROLIFERATION | 2005 |
|
RU2521394C2 |
